@xconomy.com 1 year ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com 1 year ago
Acelity Sells to 3M in Deal Valued at $6.7 Billion, Ending IPO Plan
@xconomy.com 1 year ago
San Antonio Wound-Care Company Eyes (Another) Initial Public Offering
@xconomy.com 1 year ago
San Antonio Life Science Business Acelity Cuts 260 Jobs in Texas, NC
@xconomy.com 1 year ago
Former Zavante Executive Tapped as Abide Therapeutics President